Profiel
Baxter F.
Phillips is currently an Independent Director at Cambridge Allergy Ltd. since 2018 and President of Altemia & Co. LLC.
Formerly, Mr. Phillips was Chief Operating Officer & Director at Lobe Sciences Ltd. from 2023 to 2024, President & Chief Executive Officer at Neurogastrx, Inc. from 2015 to 2017, Chief Business Officer at AmpliPhi Biosciences Corp.
from 2014 to 2015, and Head-Investor Relations at Osteologix Holdings Plc from 2010 to 2011.
Education includes an undergraduate degree from Hampden-Sydney College and an MBA from Mason School of Business of The College of William & Mary.
Actieve functies van Baxter Phillips
| Bedrijven | Functie | Begin |
|---|---|---|
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines for food allergies | Directeur/Bestuurslid | 16-10-2018 |
Altemia & Co. LLC
Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Operates as a medical food company | President | - |
Eerdere bekende functies van Baxter Phillips
| Bedrijven | Functie | Einde |
|---|---|---|
| LOBE SCIENCES LTD. | Operationeel Directeur | 12-08-2024 |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Algemeen Directeur | 01-10-2017 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Investor Relations Contact | 27-05-2015 |
| OSTEOLOGIX HOLDINGS PLC | Public Communications Contact | 01-08-2011 |
Opleiding van Baxter Phillips
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Hampden-Sydney College
Hampden-Sydney College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osteologix Holdings Plc
Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Operates as an investment holding company with interest in development of pharmaceuticals | Health Technology |
Mason School of Business of The College of William & Mary
Mason School of Business of The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines for food allergies | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Lobe Sciences Ltd.
Lobe Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops patented drug candidates to treat chronic cluster headache | Health Technology |
Altemia & Co. LLC
Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Operates as a medical food company | Health Technology |
















